Actionable news
All posts from Actionable news
Actionable news in BMY: BRISTOL-MYERS SQUIBB CO.,

Bristol-Myers (BMY) Stock Price Target Lowered at Jefferies

NEW YORK (TheStreet) -- Bristol-Myers Squibb's (BMY) stock price target was reduced to $57 from $69 at Jefferies on Monday.

The firm has a "hold" rating on shares of the New York-based biopharmaceutical company.

"We see a difficult catalyst set for BMY with numerous competitor read outs in NSCLC (non-small cell lung cancer) as well as further downside to expectations for CM-026, CM-568 and CM-227 (trials)," Jefferies wrote in an analyst note.

Additionally, the market underestimates AstraZeneca's (AZN) MYSTIC study and Roche's (RHHBY) chemo immuno-oncology trials, according to the...